Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983;2(4):499-504.
doi: 10.1002/j.1460-2075.1983.tb01453.x.

Purification of muscarinic acetylcholine receptors by affinity chromatography

Purification of muscarinic acetylcholine receptors by affinity chromatography

C André et al. EMBO J. 1983.

Abstract

Calf forebrain homogenates contain 2.8 pM muscarinic acetylcholine receptors per mg of protein. [3H]Antagonist saturation binding experiments under equilibrium conditions revealed a single class of sites with equilibrium dissociation constants of 0.82 nM for [3H]dexetimide and 0.095 nM for [3H]quinuclidinyl benzilate. Displacement binding studies with agonists revealed the presence of low and high affinity sites. Here we describe the solubilization of muscarinic acetylcholine receptors with digitonin and their purification by affinity chromatography using an affinity gel which consisted of dexetimide coupled to Affi-Gel 10 (i.e., carboxy N-hydroxysuccinimide esters linked via a 1 nm spacer arm to agarose beads). Purified proteins were obtained by specific elution with muscarinic drugs, i.e., the antagonist atropine and the irreversible ligand propylbenzilylcholine mustard. SDS-polyacrylamide gel electrophoresis of the radioiodinated purified preparations revealed a major 70-K protein.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Biochem Pharmacol. 1973 Dec 1;22(23):3099-108 - PubMed
    1. J Mol Biol. 1973 Nov 15;80(4):575-99 - PubMed
    1. Br J Pharmacol. 1974 Jan;50(1):145-51 - PubMed
    1. Biochem Biophys Res Commun. 1974 Jul 24;59(2):725-33 - PubMed
    1. Mol Pharmacol. 1974 Mar;10(2):235-47 - PubMed

Publication types